Next-generation disadvantages: Identifying potential barriers to integrating genomics into underserved medical settings

Personalized Medicine

Volumn 10, Issue 7, 2013, Pages 623-625

  Goldenberg, Aaron J ^a   Marshall, Patricia A ^a   Sharp, Richard R ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Health disparities; Next generation sequencing; Personalized genomic medicine; Underserved communities

Indexed keywords

CLINICAL PRACTICE; ENVIRONMENTAL EXPOSURE; GENE SEQUENCE; GENETIC RISK; GENETIC SCREENING; GENETIC SERVICE; GENOMICS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH DISPARITY; HUMAN; LOWEST INCOME GROUP; MEDICAL CARE; MEDICALLY UNDERSERVED; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; REVIEW; UNIVERSITY HOSPITAL;

EID: 84884126486     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/pme.13.75     Document Type: Review

References (15)

1. Burke W. Achieving Justice in Genomic Translation: Rethinking the Pathway to Benefit. Oxford University Press, NY, USA (2011).
2. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into healthcare and disease prevention? Genet. Med. 9(10), 665-674 (2007).
3. Smart A, Martin P, Parker M. Tailored medicine: whom will it fit? The ethics of patient and disease stratification. Bioethics 18(4), 322-342 (2004).
4. Singer E, Antonucci T, Van Hoewyk J. Racial and ethnic variations in knowledge and attitudes about genetic testing. Genet. Test. 8(1), 31-43 (2004).
5. Brunham LR, Hayden MR. Medicine. Whole-genome sequencing: the new standard of care? Science 336(6085), 1112-1113 (2012).
6. Boyer BB, Dillard D, Woodahl EL, Whitener R, Thummel KE, Burke W. Ethical issues in developing pharmacogenetic research partnerships with American Indigenous communities. Clin. Pharmacol. Ther. 89(3), 343-345 (2011).
7. Goldenberg AJ, Hartmann CD, Morello L, Brooks S, Colon-Zimmermann K, Marshall PA. Gene-environment interactions and health inequalities: views of underserved communities. J. Comm. Genet. doi:10.1007/s12687-013-0143-3 (2013) (Epub ahead of print).
8. Kass NE, Medley AM, Natowicz MR et al. Access to health insurance: experiences and attitudes of those with genetic versus non-genetic medical conditions. Am. J. Med. Genet. A 143(7), 707-717 (2007).
9. Suther S, Kiros GE. Barriers to the use of genetic testing: a study of racial and ethnic disparities. Genet. Med. 11(9), 655-662 (2009).
10. Feldman EA. The Genetic Information Nondiscrimination Act (GINA): public policy and medical practice in the age of personalized medicine. J. Gen. Intern. Med. 27(6), 743-746 (2012).
11. Beene-Harris RY, Wang C, Bach JV. Barriers to access: results from focus groups to identify genetic service needs in the community. Comm. Genet. 10(1), 10-18 (2007).
12. Catz DS, Green NS, Tobin JN et al. Attitudes about genetics in underserved, culturally diverse populations.Comm. Genet. 8(3), 161-172 (2005).
13. Gollust SE, Gordon ES, Zayac C et al. Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. Public Health Genom. 15(1), 22-30 (2012).
14. McGowan ML, Glinka A, Highland J, Asaad G, Sharp RR. Genetics patients' perspectives on clinical genomic testing. Pers. Med. 10(4), 339-347 (2013).
15. Sharp RR. Downsizing genomic medicine: approaching the ethical complexity of whole-genome sequencing by starting small. Genet. Med. 13(3), 191-194 (2011).